Article
Allosteric Inhibition of CRISPR-Cas9 by Bacteriophage-derived Peptides
2019-05-20
Abstract excerpt
<h4>Background</h4> CRISPR-Cas9 has been developed as a therapeutic agent for various infectious and genetic diseases. In many clinically relevant applications, constitutively active CRISPR-Cas9 is delivered into human cells without a temporal control system. Excessive and prolonged expression CRISPR-Cas9 can lead to elevated off-target cleavage. The need for modulating CRISPR-Cas9 activity over the dimensions of...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4bb1d317-7f81-51cc-849e-5fb2ed41c101
- DOI
- 10.1101/642538
